Evaluation and Management of Nocturnal Enuresis in Children

Immediate Diagnostic Priorities

In children presenting with new‑onset nocturnal enuresis, obtain a urinalysis to exclude urinary tract infection and hematuria, because infection is a common reversible cause. 1
Screen for diabetes mellitus by asking about recent weight loss, excessive thirst, or fatigue; early detection of diabetes or kidney disease is essential. 1

Directly inquire about bowel habits, as bladder and bowel function are closely interrelated in pediatric patients. 1
Constipation is likely when bowel movements occur every second day or less or when stool consistency is hard; this should raise suspicion for a contributing factor to enuresis. 1
Initiate aggressive treatment of constipation with polyethylene glycol (or similar stool softener) before other interventions, because untreated constipation can impede achievement of dryness. 1

Three principal mechanisms underlie nocturnal enuresis in children:
Not all children with nocturnal polyuria have vasopressin deficiency, and not all with polyuria wet the bed; sleep‑related factors also play a role. 1

Ask about daytime urinary symptoms such as urgency, holding maneuvers (e.g., standing on tiptoe, pressing heel into perineum), interrupted stream, weak stream, or the need to use abdominal pressure to void; these clues help differentiate detrusor overactivity from other mechanisms. 1
Determine whether the enuresis is primary (never achieved ≥6 consecutive dry months) or secondary (previously dry for ≥6 months); secondary enuresis suggests a new underlying pathology. 1

Immediate specialist evaluation is warranted if the child exhibits any of the following: weak urinary stream, continuous incontinence, recurrent urinary tract infections, or abnormal neurological findings. 1
Children who void with a weak stream, must employ abdominal pressure, or have continuous incontinence should be referred to a specialized pediatric urology or nephrology center without delay. 1

Use the formula “age (years) + 2 = functional bladder capacity (ounces)” to estimate expected bladder capacity and identify reduced capacity during bladder‑diary analysis. 2
Recognize that chronic nocturnal enuresis can cause significant psychological sequelae—including anxiety, lowered self‑esteem, and delayed developmental milestones—that may be more detrimental than the physical symptom itself. 2

The American Academy of Child and Adolescent Psychiatry recommends a combination of desmopressin and alarm therapy for treatment-resistant enuresis 3
The American Academy of Pediatrics suggests that bedwetting is involuntary and that punitive parental responses should be avoided 4

A urine dipstick test should be performed immediately to exclude diabetes mellitus and kidney disease, with glycosuria requiring urgent blood glucose testing, as recommended by the American Diabetes Association 5, 6
The child's bowel habits should be assessed, with constipation treated aggressively first, using polyethylene glycol as a stool softener (Grade Ia evidence), as suggested by the North American Society for Pediatric Gastroenterology 5, 7, 4
A frequency-volume chart (bladder diary) should be completed for at least 2 days of measured intake/output and 1 week of wet/dry nights to objectively detect nocturnal polyuria and identify children with polydipsia, as recommended by the International Children's Continence Society 8, 7

Enuresis alarm therapy is the first-line treatment for monosymptomatic enuresis in children aged 6+, with a long-term cure rate of 66% initial response and >50% long-term cure, as recommended by the American Academy of Pediatrics 3, 4
Desmopressin may be used when rapid or short-term response is needed, with a 30% full response and 40% partial response (Grade Ia evidence), but has low curative potential, as suggested by the European Society for Pediatric Urology 8, 7, 3
The dosage of desmopressin is 0.2-0.4 mg or 120-240 µg, taken 1 hour before sleep (tablets) or 30-60 minutes before sleep (melt formulation), with a critical safety warning to avoid water intoxication, hyponatremia, and convulsions due to excessive fluid intake, as recommended by the Food and Drug Administration 9, 3, 4

Monthly follow-up is necessary to sustain motivation and assess response, with treatment continued for at least 2-3 months before declaring failure, as recommended by the American Academy of Child and Adolescent Psychiatry 3, 4
With desmopressin, families can choose daily use or only before important nights, with regular short drug holidays to assess ongoing need, as suggested by the International Children's Continence Society 9

Urgent referral is needed if the child has weak urinary stream, continuous incontinence, recurrent urinary tract infections, abnormal neurological findings, or non-monosymptomatic enuresis that doesn't respond to initial management, as recommended by the American Academy of Pediatrics 4, 5